Monitoring volume status using bioelectrical impedance analysis in chronic hemodialysis patients

ASAIO Journal

Volumn 64, Issue 2, 2018, Pages 245-252

  Kim, Chae Rim ^a   Shin, Jung Ho ^a   Hwang, Jin Ho ^a   Kim, Su Hyun ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRIC IMPEDANCE; EPIDEMIOLOGY; HEMODIALYZERS;

BIOELECTRICAL IMPEDANCE ANALYSIS; CARDIOVASCULAR EVENT; CO MORBIDITIES; CONFIDENCE INTERVAL; END-STAGE RENAL DISEASE PATIENTS; HEMODIALYSIS PATIENT; INTERMITTENT CONTROLS; TOTAL BODY WATER;

DIALYSIS;

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ALL CAUSE MORTALITY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; END STAGE RENAL DISEASE; EXTRACELLULAR FLUID; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX; TOTAL BODY WATER; AGED; BODY COMPOSITION; BODY FLUID; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; MORTALITY;

ADULT; AGED; BODY COMPOSITION; BODY FLUIDS; CARDIOVASCULAR DISEASES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 85021672761     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000619     Document Type: Article

References (35)

1. Jaeger JQ, Mehta RL: Assessment of dry weight in hemodialysis: An overview. J Am Soc Nephrol 10: 392-403, 1999.
2. Parrinello G, Torres D, Paterna S, di Pasquale P, Licata G: The pathophysiology of acute heart failure: The key role of fluid accumulation. Am Heart J 156: e19, 2008.
3. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119: 671-679, 2009.
4. Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight reduction in hypertensive hemodialysis patients (DRIP): A randomized controlled trial. Hypertension 53: 500-507, 2009.
5. Agarwal R, Weir MR: Dry-weight: A concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 5: 1255-1260, 2010.
6. Ozkahya M, Ok E, Toz H, et al: Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 21: 3506-3513, 2006.
7. Dou Y, Zhu F, Kotanko P: Assessment of extracellular fluid volume and fluid status in hemodialysis patients: Current status and technical advances. Semin Dial 25: 377-387, 2012.
8. Susantitaphong P, Laowaloet S, Tiranathanagul K, et al: Reliability of blood pressure parameters for dry weight estimation in hemodialysis patients. Ther Apher Dial 17: 9-15, 2013.
9. Cataliotti A, Malatino LS, Jougasaki M, et al: Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76: 1111-1119, 2001.
10. Chamney PW, Krämer M, Rode C, Kleinekofort W, Wizemann V: A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 61: 2250-2258, 2002.
11. Lopot F, Nejedlý B, Novotná H, Macková M, Sulková S: Agerelated extracellular to total body water volume ratio (Ecv/ TBW)-can it be used for "dry weight" determination in dialysis patients? Application of multifrequency bioimpedance measurement. Int J Artif Organs 25: 762-769, 2002.
12. Tangvoraphonkchai K, Davenport A: Pre-dialysis and post-dialysis hydration status and N-terminal pro-brain natriuretic peptide and survival in haemodialysis patients. Int J Artif Organs 39: 282-287, 2016.
13. Kim EJ, Choi MJ, Lee JH, et al: Extracellular fluid/intracellular fluid volume ratio as a novel risk indicator for all-cause mortality and cardiovascular disease in hemodialysis patients. PLoS One 12: e0170272, 2017.
14. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108: 609-613, 2000.
15. Depner TA, Daugirdas JT: Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 7: 780-785, 1996.
16. Zhu F, Schneditz D, Wang E, Martin K, Morris AT, Levin NW: Validation of changes in extracellular volume measured during hemodialysis using a segmental bioimpedance technique. ASAIO J 44: M541-M545, 1998.
17. Davies SJ, Davenport A: The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 86: 489-496, 2014.
18. Chan C, McIntyre C, Smith D, Spanel P, Davies SJ: Combining nearsubject absolute and relative measures of longitudinal hydration in hemodialysis. Clin J Am Soc Nephrol 4: 1791-1798, 2009.
19. Charra B, Chazot C: Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol 93: p94-p101, 2003.
20. Agarwal R, Andersen MJ, Pratt JH: On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 3: 153-158, 2008.
21. Natori H, Tamaki S, Kira S: Ultrasonographic evaluation of ventilatory effect on inferior vena caval configuration. Am Rev Respir Dis 120: 421-427, 1979.
22. Tiba MH, Belmont B, Heung M, et al: Dynamic limb bioimpedance and inferior vena cava ultrasound in patients undergoing hemodialysis. ASAIO J 62: 463-469, 2016.
23. Bargnoux AS, Klouche K, Fareh J, et al: Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration. Clin Chem Lab Med 46: 1019-1024, 2008.
24. Takase H, Dohi Y: Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship. Eur J Clin Invest 44: 303-308, 2014.
25. Aurigemma GP, Gaasch WH: Clinical practice. Diastolic heart failure. N Engl J Med 351: 1097-1105, 2004.
26. Kyle UG, Bosaeus I, De Lorenzo AD, et al; ESPEN: Bioelectrical impedance analysis-part II: Utilization in clinical practice. Clin Nutr 23: 1430-1453, 2004.
27. Moissl U, Arias-Guillén M, Wabel P, et al: Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol 8: 1575-1582, 2013.
28. Tapolyai M, Faludi M, Réti V, Lengvárszky Z, Szarvas T, Berta K: Dialysis patients' fluid overload, antihypertensive medications, and obesity. ASAIO J 57: 511-515, 2011.
29. Tsai YC, Chiu YW, Tsai JC, et al: Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol 10: 39-46, 2015.
30. Fagugli RM, Reboldi G, Quintaliani G, et al: Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38: 371-376, 2001.
31. Zamboli P, De Nicola L, Minutolo R, et al: Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: A randomized controlled trial. Nephrol Dial Transplant 26: 1575-1583, 2011.
32. Bock JS, Gottlieb SS: Cardiorenal syndrome: New perspectives. Circulation 121: 2592-2600, 2010.
33. Giachelli CM: The emerging role of phosphate in vascular calcification. Kidney Int 75: 890-897, 2009.
34. Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V: Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant 27: 2404-2410, 2012.
35. Kim YJ, Jeon HJ, Kim YH, et al: Overhydration measured by bioimpedance analysis and the survival of patients on maintenance hemodialysis: A single-center study. Kidney Res Clin Pract 34: 212-218, 2015.